Functional impairment in the remission phase of bipolar disorder.

PubWeight™: 1.64‹?› | Rank: Top 3%

🔗 View Article (PMID 15898966)

Published in Bipolar Disord on June 01, 2005

Authors

Andrea Fagiolini1, David J Kupfer, Azadeh Masalehdan, John A Scott, Patricia R Houck, Ellen Frank

Author Affiliations

1: Department of Psychiatry, University of Pittsburgh School of Medicine, Western Psychiatric Institute and Clinic, Pittsburgh, PA 15213, USA. fagiolinia@upmc.edu

Articles citing this

Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov (2008) 4.46

Bipolar disorder: new perspectives in health care and prevention. J Clin Psychiatry (2010) 2.48

Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry (2007) 2.43

Adjunctive psychotherapy for bipolar disorder: state of the evidence. Am J Psychiatry (2008) 1.55

Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health (2007) 1.52

Glutamatergic modulators: the future of treating mood disorders? Harv Rev Psychiatry (2010) 1.42

The relationship between religious involvement and clinical status of patients with bipolar disorder. Bipolar Disord (2010) 1.39

Psychosocial functioning among bipolar youth. J Affect Disord (2008) 1.37

BAG1 plays a critical role in regulating recovery from both manic-like and depression-like behavioral impairments. Proc Natl Acad Sci U S A (2008) 1.25

RESEARCH: Cognitive rehabilitation for bipolar disorder: An open trial for employed patients with residual depressive symptoms. CNS Neurosci Ther (2010) 1.19

Neural circuitry and neuroplasticity in mood disorders: insights for novel therapeutic targets. NeuroRx (2006) 1.19

The psychopathology and treatment of bipolar disorder. Annu Rev Clin Psychol (2006) 1.18

The role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders. Neuroscientist (2009) 1.13

Neuropsychological and socio-occupational functioning in young psychiatric outpatients: a longitudinal investigation. PLoS One (2013) 0.95

The phenomenology of bipolar disorder: what drives the high rate of medical burden and determines long-term prognosis? Depress Anxiety (2009) 0.94

A comparison of cognitive functioning in medicated and unmedicated subjects with bipolar depression. Bipolar Disord (2008) 0.93

Psychosocial functioning in offspring of parents with bipolar disorder. J Affect Disord (2011) 0.91

Mood and anxiety spectrum as a means to identify clinically relevant subtypes of bipolar I disorder. Bipolar Disord (2007) 0.90

Borderline personality disorder and the misdiagnosis of bipolar disorder. J Psychiatr Res (2009) 0.85

Linkage disequilibrium mapping of the chromosome 6q21-22.31 bipolar I disorder susceptibility locus. Am J Med Genet B Neuropsychiatr Genet (2010) 0.83

Validity and reliability of the Structured Clinical Interview for the Trauma and Loss Spectrum (SCI-TALS). Clin Pract Epidemiol Ment Health (2008) 0.82

Mood Spectrum Model: Evidence reconsidered in the light of DSM-5. World J Psychiatry (2015) 0.82

Disability in patients with bipolar and recurrent depressive disorder in remission: a comparative study. Indian J Psychol Med (2011) 0.81

Validity and Reliability of the Italian Version of the Functioning Assessment Short Test (FAST) in Bipolar Disorder. Clin Pract Epidemiol Ment Health (2012) 0.81

Genetic association of cyclic AMP signaling genes with bipolar disorder. Transl Psychiatry (2012) 0.81

Social support and social strain in inter-episode bipolar disorder. Bipolar Disord (2012) 0.81

The Influence of Trauma, Life Events, and Social Relationships on Bipolar Depression. Psychiatr Clin North Am (2015) 0.80

Role of quetiapine beyond its clinical efficacy in bipolar disorder: From neuroprotection to the treatment of psychiatric disorders (Review). Exp Ther Med (2015) 0.80

NMDA Receptor Antagonists for Treatment of Depression. Pharmaceuticals (Basel) (2013) 0.79

Dimensional psychopathology in preschool offspring of parents with bipolar disorder. J Child Psychol Psychiatry (2013) 0.79

Emotion perception and quality of life in bipolar I disorder. J Affect Disord (2013) 0.79

Inter-episode affective intensity and instability: predictors of depression and functional impairment in bipolar disorder. J Behav Ther Exp Psychiatry (2014) 0.78

CPAP-induced mania in bipolar disorder: a case report. Bipolar Disord (2013) 0.77

Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments. Depress Anxiety (2011) 0.77

Bipolar disorder in children. Psychiatry J (2014) 0.76

Psychosocial Functioning in Depressive Patients: A Comparative Study between Major Depressive Disorder and Bipolar Affective Disorder. Depress Res Treat (2014) 0.76

Elevated striatal reactivity across monetary and social rewards in bipolar I disorder. J Abnorm Psychol (2015) 0.76

Associations between sleep disturbance, cognitive functioning and work disability in Bipolar Disorder. Psychiatry Res (2015) 0.76

Mental disorders, functional impairment, and nerve growth factor. Psychol Res Behav Manag (2016) 0.75

Feasibility randomised controlled trial of Recovery-focused Cognitive Behavioural Therapy for Older Adults with bipolar disorder (RfCBT-OA): study protocol. BMJ Open (2016) 0.75

Personality disorder symptom severity predicts onset of mood episodes and conversion to bipolar I disorder in individuals with bipolar spectrum disorder. J Abnorm Psychol (2017) 0.75

Emerging Novel Treatments for Severe Mood Disorders Involving Cellular Plasticity Cascades. Curr Psychos Ther Rep (2006) 0.75

[Factors predicting functioning in type 1 bipolar patients during remission period]. Pan Afr Med J (2016) 0.75

Longitudinal course and characteristics of cyclothymic disorder in youth. J Affect Disord (2017) 0.75

Articles by these authors

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry (2006) 12.41

Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol (2008) 7.95

Maintenance treatment of major depression in old age. N Engl J Med (2006) 7.61

The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry (2009) 6.71

Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials (2004) 6.64

Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet (2003) 5.75

Treatment of complicated grief: a randomized controlled trial. JAMA (2005) 5.15

Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am (2003) 5.05

Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry (2005) 4.84

Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med (2003) 4.30

Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial. JAMA (2009) 4.06

How and why criteria defining moderators and mediators differ between the Baron & Kenny and MacArthur approaches. Health Psychol (2008) 4.04

Moderators of treatment outcomes: clinical, research, and policy importance. JAMA (2006) 4.03

Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology (2006) 3.80

Development of a computerized adaptive test for depression. Arch Gen Psychiatry (2012) 3.77

Efficacy of brief behavioral treatment for chronic insomnia in older adults. Arch Intern Med (2011) 3.73

A new approach to integrating data from multiple informants in psychiatric assessment and research: mixing and matching contexts and perspectives. Am J Psychiatry (2003) 3.66

Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry (2003) 3.60

DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry (2013) 3.58

Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program. Arch Gen Psychiatry (2007) 3.38

The future of psychiatry as clinical neuroscience. Acad Med (2009) 3.31

Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry (2005) 3.23

Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry (2004) 2.87

Using computerized adaptive testing to reduce the burden of mental health assessment. Psychiatr Serv (2008) 2.68

The conceptual development of DSM-V. Am J Psychiatry (2009) 2.65

Bipolar disorder: new perspectives in health care and prevention. J Clin Psychiatry (2010) 2.48

Intensive psychosocial intervention enhances functioning in patients with bipolar depression: results from a 9-month randomized controlled trial. Am J Psychiatry (2007) 2.43

Medication effects in neuroimaging studies of bipolar disorder. Am J Psychiatry (2008) 2.41

Neuroscience, clinical evidence, and the future of psychiatric classification in DSM-5. Am J Psychiatry (2011) 2.35

Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry (2013) 2.30

DSM-5: how reliable is reliable enough? Am J Psychiatry (2012) 2.30

Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry (2007) 2.27

Brief interpersonal psychotherapy for depressed mothers whose children are receiving psychiatric treatment. Am J Psychiatry (2008) 2.25

Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk. Proc Natl Acad Sci U S A (2012) 2.22

The confluence of mental, physical, social, and academic difficulties in middle childhood. II: developing the Macarthur health and Behavior Questionnaire. J Am Acad Child Adolesc Psychiatry (2002) 2.19

Role of intense affects in predicting short-term risk for suicidal behavior: a prospective study. J Nerv Ment Dis (2010) 2.17

Development of the CAT-ANX: a computerized adaptive test for anxiety. Am J Psychiatry (2014) 2.16

Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. J Psychiatr Res (2003) 2.14

The mood spectrum in unipolar and bipolar disorder: arguments for a unitary approach. Am J Psychiatry (2004) 2.13

Demographic and clinical characteristics of individuals in a bipolar disorder case registry. J Clin Psychiatry (2002) 2.12

Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord (2005) 2.12

Randomized, placebo-controlled trial of fluoxetine for acute treatment of minor depressive disorder. Am J Psychiatry (2004) 2.11

The computerized adaptive diagnostic test for major depressive disorder (CAD-MDD): a screening tool for depression. J Clin Psychiatry (2013) 2.10

Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet (2011) 2.10

Computerized adaptive measurement of depression: a simulation study. BMC Psychiatry (2004) 2.08

A randomized controlled trial of culturally relevant, brief interpersonal psychotherapy for perinatal depression. Psychiatr Serv (2009) 2.08

Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania. Bipolar Disord (2003) 2.07

Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2004) 2.04

A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia. Am J Geriatr Psychiatry (2007) 2.04

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy. Arch Gen Psychiatry (2002) 2.01

Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder. J Psychiatr Res (2013) 1.99

Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med (2006) 1.96

The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord (2009) 1.91

Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord (2009) 1.90

Exploring risk factors for the emergence of children's mental health problems. Arch Gen Psychiatry (2006) 1.88

Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol (2007) 1.87

Family-based treatment of severe pediatric obesity: randomized, controlled trial. Pediatrics (2009) 1.87

Self-reported sleep quality predicts poor cognitive performance in healthy older adults. J Gerontol B Psychol Sci Soc Sci (2009) 1.85

Placebo in clinical trials for depression: complexity and necessity. JAMA (2002) 1.83

Elevated left and reduced right orbitomedial prefrontal fractional anisotropy in adults with bipolar disorder revealed by tract-based spatial statistics. Arch Gen Psychiatry (2008) 1.83

Stressful life events precede exacerbations of multiple sclerosis. Psychosom Med (2002) 1.74

Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry (2003) 1.73

Elevated striatal and decreased dorsolateral prefrontal cortical activity in response to emotional stimuli in euthymic bipolar disorder: no associations with psychotropic medication load. Bipolar Disord (2008) 1.71

Daytime symptoms in primary insomnia: a prospective analysis using ecological momentary assessment. Sleep Med (2007) 1.69

Recovery from major depression in older adults receiving augmentation of antidepressant pharmacotherapy. Am J Psychiatry (2007) 1.68

Circadian rhythm disturbances in depression. Hum Psychopharmacol (2008) 1.66

A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Arch Gen Psychiatry (2005) 1.65

Elevated amygdala activity to sad facial expressions: a state marker of bipolar but not unipolar depression. Biol Psychiatry (2009) 1.65

The prevalence and correlates of psychiatric comorbidity in individuals with complicated grief. Compr Psychiatry (2007) 1.59

Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2014) 1.57

MRI investigation of temporal lobe structures in bipolar patients. J Psychiatr Res (2003) 1.54

Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy. J Am Geriatr Soc (2007) 1.50